ATE366419T1 - Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken - Google Patents

Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken

Info

Publication number
ATE366419T1
ATE366419T1 AT00991344T AT00991344T ATE366419T1 AT E366419 T1 ATE366419 T1 AT E366419T1 AT 00991344 T AT00991344 T AT 00991344T AT 00991344 T AT00991344 T AT 00991344T AT E366419 T1 ATE366419 T1 AT E366419T1
Authority
AT
Austria
Prior art keywords
epitope
libraries
selection
binding compounds
library
Prior art date
Application number
AT00991344T
Other languages
English (en)
Inventor
Ton Logtenberg
Original Assignee
Crucell Holland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holland Bv filed Critical Crucell Holland Bv
Application granted granted Critical
Publication of ATE366419T1 publication Critical patent/ATE366419T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00991344T 1999-12-27 2000-12-21 Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken ATE366419T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204561 1999-12-27

Publications (1)

Publication Number Publication Date
ATE366419T1 true ATE366419T1 (de) 2007-07-15

Family

ID=8241110

Family Applications (3)

Application Number Title Priority Date Filing Date
AT00991344T ATE366419T1 (de) 1999-12-27 2000-12-21 Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken
AT04102692T ATE353920T1 (de) 1999-12-27 2000-12-21 Menschlischer monoklonaler antikörper gegen ep- cam und dessen verwendung in krebstherapie
AT02077516T ATE386747T1 (de) 1999-12-27 2000-12-21 Antikörper gegen ep-cam

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT04102692T ATE353920T1 (de) 1999-12-27 2000-12-21 Menschlischer monoklonaler antikörper gegen ep- cam und dessen verwendung in krebstherapie
AT02077516T ATE386747T1 (de) 1999-12-27 2000-12-21 Antikörper gegen ep-cam

Country Status (11)

Country Link
US (2) US20030096225A1 (de)
EP (3) EP1273918B1 (de)
JP (1) JP2003518391A (de)
AT (3) ATE366419T1 (de)
AU (1) AU783148B2 (de)
CA (1) CA2396029A1 (de)
DE (3) DE60038132T2 (de)
DK (1) DK1479696T3 (de)
ES (1) ES2282797T3 (de)
NZ (2) NZ531590A (de)
WO (1) WO2001048485A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658924B2 (en) 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
EP1495142B1 (de) * 2002-04-17 2007-09-26 Bioren, Inc. Doping bei der walk-through-mutagenese
PT2314629E (pt) 2002-07-18 2014-01-22 Merus B V Produção recombinante de misturas de anticorpos
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
EP2395016A3 (de) 2003-05-30 2012-12-19 Merus B.V. Entwurf und Verwendung von gepaarten unterschiedlichen Regionen von spezifisch bindenden Molekülen
WO2005025505A2 (en) * 2003-09-08 2005-03-24 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
JP5912211B2 (ja) 2004-01-20 2016-04-27 メルス ビー．ヴィー． 結合タンパク質の混合物
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
US9079942B2 (en) 2009-02-09 2015-07-14 Epitomics, Inc. CDR-anchored amplification method
GB0909904D0 (en) 2009-06-09 2009-07-22 Affitech As Product
US8293483B2 (en) 2009-09-11 2012-10-23 Epitomics, Inc. Method for identifying lineage-related antibodies
US9541480B2 (en) 2011-06-29 2017-01-10 Academia Sinica Capture, purification, and release of biological substances using a surface coating
CA2791109C (en) 2011-09-26 2021-02-16 Merus B.V. Generation of binding molecules
WO2013131001A1 (en) * 2012-03-02 2013-09-06 Academia Sinica ANTI-EPITHELIAL CELL ADHESION MOLECULE (EpCAM) ANTIBODIES AND METHODS OF USE THEREOF
DK2838917T3 (da) 2012-04-20 2019-08-26 Merus Nv Fremgangsmåder og midler til frembringelse af heterodimere ig-lignende molekyler
TW201623605A (zh) 2014-04-01 2016-07-01 中央研究院 用於癌症診斷及預後之方法及系統
CN105381824B (zh) 2014-08-26 2019-04-23 中央研究院 收集器架构布局设计
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
CA3097938A1 (en) * 2018-05-04 2019-11-07 The Regents Of The University Of California Spiked primers for enrichment of pathogen nucleic acids among background of nucleic acids
EP4136123A4 (de) * 2020-04-13 2024-06-12 Affyimmune Therapeutics, Inc. Epcam-antikörper und car-t-zellen
EP4259285A4 (de) * 2020-12-09 2024-12-11 Affyimmune Therapeutics, Inc. Dualer chimärer antigenrezeptor gegen epcam und icam-1
WO2023174521A1 (en) 2022-03-15 2023-09-21 Genmab A/S Binding agents binding to epcam and cd137
WO2025056180A1 (en) 2023-09-15 2025-03-20 BioNTech SE Methods of treatment using agents binding to epcam and cd137 in combination with pd-1 axis binding antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6265150B1 (en) * 1995-06-07 2001-07-24 Becton Dickinson & Company Phage antibodies
DK0934526T3 (da) * 1996-10-08 2003-05-05 Bisys B V U Fremgangsmåder og midler til udvælgelse af peptider og proteiner, der har specifik affinitet til et mål
US6787638B1 (en) * 1998-12-02 2004-09-07 Applied Molecular Evolution, Inc. Tumor specific human monoclonal antibodies and methods of use

Also Published As

Publication number Publication date
JP2003518391A (ja) 2003-06-10
EP1273918A2 (de) 2003-01-08
EP1479696A1 (de) 2004-11-24
AU783148B2 (en) 2005-09-29
DE60038132T2 (de) 2009-04-02
ATE386747T1 (de) 2008-03-15
EP1242823A2 (de) 2002-09-25
EP1273918B1 (de) 2008-02-20
DE60035434D1 (de) 2007-08-16
EP1242823B1 (de) 2007-07-04
AU3244701A (en) 2001-07-09
WO2001048485A3 (en) 2002-01-31
DE60035434T2 (de) 2008-05-15
DE60033455T2 (de) 2007-11-29
US20030096225A1 (en) 2003-05-22
CA2396029A1 (en) 2001-07-05
ES2282797T3 (es) 2007-10-16
DK1479696T3 (da) 2007-05-07
NZ531590A (en) 2006-01-27
ATE353920T1 (de) 2007-03-15
WO2001048485A2 (en) 2001-07-05
DE60038132D1 (de) 2008-04-03
DE60033455D1 (de) 2007-03-29
US7777010B2 (en) 2010-08-17
EP1479696B1 (de) 2007-02-14
WO2001048485A9 (en) 2002-09-06
NZ520074A (en) 2004-04-30
EP1273918A3 (de) 2003-05-02
US20030096226A1 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
ATE366419T1 (de) Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken
DK0920631T3 (da) Fremgangsmåde til identifikation af forbindelser, som indvirker på interaktioner mellem RNA og RNA-bindende proteiner
WO2005052644A3 (en) Optical device integrated with well
DK1252328T3 (da) Fremgangsmåde og midler til isolering af mikroorganismer
ATE466280T1 (de) Versuchsanordnung zum nachweis von bindungspartnern
WO2003073817A3 (en) Rapid and sensitive detection of cells and viruses
WO2003062402A3 (en) Use of collections of binding sites for sample profiling and other applications
WO2003029458A3 (de) Verfahren zur herstellung von protein-bibliotheken und zur selektion von proteinen daraus
TR200001313T2 (tr) Protein etkileşimlerini ve fonksiyonel ilişkileri kaydeden tarama sistemleri
PT868427E (pt) Metodos para identificar compostos que se ligam a um alvo
NO996141D0 (no) Fremgangsmåte til å sortere seismiske data
NO20083610L (no) Cobalamin-maling
MY140649A (en) Method for splitting a data stream
ATE378399T1 (de) Magnetische manipulation von biologischen proben
WO2001038566A3 (en) Screening method for candidate drugs
WO1999030165A3 (en) Processes for identifying a solvent condition suitable for determining a biophysical property of a protein
DE69732034D1 (de) Assay-verfahren
ATE319735T1 (de) Aufreinigung von substanzen aus einer biologischen probe
DK1328657T3 (da) Proces til påvisning af serin-/threoninkinaseaktivitet
WO2000075657A3 (de) Screening von target-ligand-wechselwirkungen
IS5620A (is) Greiningar aðferðir
EA199800843A1 (ru) Компьютерный способ создания химических структур, имеющих общие функциональные характеристики
DE59809534D1 (de) Verfahren zur Bearbeitung von Zapfen an Tripoden
AU2986395A (en) Method for screening compound libraries
NO991379D0 (no) FremgangsmÕte ved innarbeidelse av en aktiv substans i en st°pt plastdel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties